Neochem Bio Solutions Ltd
Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.[1]
- Market Cap ₹ 118 Cr.
- Current Price ₹ 68.9
- High / Low ₹ 113 / 63.0
- Stock P/E 15.3
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 27.2 %
- ROE 48.4 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.0%
Cons
- Promoter holding has decreased over last quarter: -24.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 48.19 | 61.15 | 84.17 | |
| 43.95 | 55.16 | 71.05 | |
| Operating Profit | 4.24 | 5.99 | 13.12 |
| OPM % | 8.80% | 9.80% | 15.59% |
| 0.60 | 0.86 | 1.98 | |
| Interest | 2.10 | 2.96 | 3.51 |
| Depreciation | 1.22 | 1.22 | 1.33 |
| Profit before tax | 1.52 | 2.67 | 10.26 |
| Tax % | 28.95% | 32.58% | 24.46% |
| 1.07 | 1.80 | 7.75 | |
| EPS in Rs | 1.97 | 2.70 | 11.61 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 330% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 31% |
| Last Year: | 48% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 5.43 | 6.68 | 6.68 |
| Reserves | 2.63 | 5.33 | 13.08 |
| 26.24 | 33.32 | 35.63 | |
| 16.31 | 18.73 | 23.50 | |
| Total Liabilities | 50.61 | 64.06 | 78.89 |
| 14.67 | 18.81 | 18.67 | |
| CWIP | 0.04 | 0.03 | 0.06 |
| Investments | 0.00 | 0.00 | 0.00 |
| 35.90 | 45.22 | 60.16 | |
| Total Assets | 50.61 | 64.06 | 78.89 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -0.74 | 1.96 | 2.59 | |
| -3.35 | -7.86 | -1.69 | |
| 3.76 | 6.20 | -1.20 | |
| Net Cash Flow | -0.34 | 0.30 | -0.30 |
| Free Cash Flow | -4.07 | -3.37 | 1.45 |
| CFO/OP | -11% | 40% | 26% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 109.22 | 102.90 | 109.63 |
| Inventory Days | 174.77 | 172.24 | 157.02 |
| Days Payable | 156.98 | 133.36 | 107.72 |
| Cash Conversion Cycle | 127.01 | 141.78 | 158.93 |
| Working Capital Days | 20.53 | 32.29 | 39.33 |
| ROCE % | 14.09% | 27.20% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Actual Production Volume MT ・Standalone data |
|
||
| Capacity Utilization % ・Standalone data |
|||
| Installed Production Capacity MTPA ・Standalone data |
|||
| Number of Domestic Customers count ・Standalone data |
|||
| Number of Export Countries count ・Standalone data |
|||
| Number of Export Customers count ・Standalone data |
|||
Documents
Announcements
-
Trading Window
30 March 2026 - Trading window closed from April 1, 2026 until 48 hours after audited results for year ended March 31, 2026.
-
Updates
21 March 2026 - Promoter Swapnil Rameshbhai Makati purchased 2,400 shares on 20 Mar 2026; holding 9,346,475 (54.57%).","checklist":["Review announcement and regulatory reference (SEBI PIT Reg 7(2))","Identify transacting party, shares, …
-
Updates
14 March 2026 - Promoter bought 2,400 shares on 13-Mar-2026; holding now 9,344,075 (54.57%).
-
Investor Presentation
5 March 2026 - Investor presentation: Red Herring Prospectus filed for proposed IPO; FY25 revenue ₹8,400 Lakhs; 22,000 MTPA capacity.
-
Analysts/Institutional Investor Meet/Con. Call Updates
5 March 2026 - Analyst/Institutional investor meeting on March 10, 2026 at Taj Santacruz, Mumbai (9:00 AM–6:00 PM); no UPSI.
Concalls
-
Mar 2026TranscriptAI SummaryPPT
Business Profile[1]
Operates as a specialty performance chemical company with 350+ customized formulations across four primary product segments, ''Polymers, Surfactants, Silicones and esters/bio-based sustainable solutions''.